# CARBAMAZEPINE
> **ANDA215664** · Abbreviated New Drug Application (Generic) · Sponsor: OSMOTICA PHARM US · Approved 2024-10-22
## Drug
- **FDA Application Number:** ANDA215664
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARBAMAZEPINE
- **Generic name:** Carbamazepine
- **Active ingredients:** CARBAMAZEPINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** OSMOTICA PHARM US
- **First approval:** 2024-10-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215664)
---
*AI Analytics · CC0 1.0*